Pharmafile Logo
Pharmafocus logo
Advanced Search

Making and shaping the headlines

March 15, 2006
Medical Communications

Most companies are anxious to court the media to ensure a clearer understanding of their business focus. However, the first …

Feature

A place in pharma’s history of innovation

March 15, 2006
Sales and Marketing prix galien

Registration has begun for entrants to the 2006 UK Prix Galien, which takes place at the Houses of Parliament this …

Feature

New NHS ratings take tougher line on financial performance

March 15, 2006

New NHS performance ratings will put equal emphasis on a trust's quality of care and financial management. The independent watchdog, …

News

Crestor hailed as first drug to reverse cardiovascular disease

March 14, 2006
Research and Development

Researchers have hailed results from a new study of Crestor which shows it can reverse atherosclerosis, the furring up of …

News

Schering to fight takeover bid from Merck KGaA

March 14, 2006
Sales and Marketing

A hostile takeover bid has been launched by Merck KGaA for rival German pharmaceutical company Schering.Both companies are enjoying strong …

News

We’re part of the solution, pharma tells Europe

March 13, 2006
Sales and Marketing

Europe’s pharmaceutical industry body EFPIA has launched a new promotional campaign for the sector, which it hopes will raise awareness …

News

NHS chief executive resigns amid financial crisis

March 10, 2006

NHS chief executive Nigel Crisp is to step down from the post as debts deepen in the health service.Significant improvements …

News

Bright future for NicOx after Pfizer glaucoma deal

March 10, 2006
Research and Development

Shares in the French biotechnology company NicOx have soared after Pfizer snapped up the rights to its pipeline of ophthalmology …

News

New Novartis blindness treatment filed in Europe

March 2, 2006
Sales and Marketing AMD, Lucentis, Novartis

Lucentis, a new treatment for neovascular age-related macular degeneration or ‘wet AMD’ has been submitted by Novartis to the European …

News

Herceptin challenges put patient safety at risk, says survey

March 2, 2006

NHS managers have warned that the sidelining of the normal regulatory process for new medicines will put patient safety at …

News

GSK launches Europe’s first rotavirus vaccine

March 1, 2006
Sales and Marketing

GlaxoSmithKline has launched Rotarix in Europe, the first ever marketed vaccine against rotavirus gastroenteritis, a common but potentially lethal condition …

News

Bioenvision’s leukaemia treatment gains positive opinion

March 1, 2006
Sales and Marketing

Bioenvision has received a positive opinion from the European Medicines Agency for Evoltra (clofarabine), the first drug specifically developed for …

News

Erbitux closer to head and neck cancer approval

March 1, 2006
Sales and Marketing

Merck KGaA's targeted cancer treatment Erbitux has moved a step closer to receiving EU approval to extend its licence to …

News

Novartis files new Hepatitis B treatment in Europe

February 28, 2006
Sales and Marketing

Novartis has filed its new hepatitis B treatment telbivudine in the European Union, and says it represents a potential new …

News

ABPI chief calls for ‘new rules of engagement’

February 23, 2006
Sales and Marketing

UK pharmaceutical industry leader Richard Barker has called for a fundamental rethink in the way the industry and the NHS …

News

Gene silencing technology to be used in war against bird flu

February 23, 2006
Sales and Marketing

Cutting edge technology will be used develop new drugs to treat dangerous strains of influenza, including the threat of a …

News

Wyeth to open clinical trial ‘Super Centres’

February 23, 2006
Research and Development

Wyeth has unveiled plans to streamline its drug development operations by opening a network of clinical trial 'Super Centres' around …

News

Pfizer’s new blood infection drug Eraxis approved

February 23, 2006
Research and Development

Eraxis, a new treatment for potentially life-threatening fungal infections has been approved in the US.Pfizer's new antifungal is licensed to …

News

Sanofi’s wonder drug in limbo after regulator’s rejection

February 23, 2006
Sales and Marketing

The future of Sanofi-Aventis' Acomplia is in serious doubt after regulators demanded more data for its use in weight loss, …

News

Pegasys recommended as front line hepatitis B treatment

February 23, 2006
Sales and Marketing

Roche's Pegasys is set to be used more widely in England and Wales to treat hepatitis B following the release …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026